326 related articles for article (PubMed ID: 24026675)
1. Validation of the auto-inflammatory diseases activity index (AIDAI) for hereditary recurrent fever syndromes.
Piram M; Koné-Paut I; Lachmann HJ; Frenkel J; Ozen S; Kuemmerle-Deschner J; Stojanov S; Simon A; Finetti M; Sormani MP; Martini A; Gattorno M; Ruperto N;
Ann Rheum Dis; 2014 Dec; 73(12):2168-73. PubMed ID: 24026675
[TBL] [Abstract][Full Text] [Related]
2. Use of the Auto-inflammatory Disease Activity Index to monitor disease activity in patients with colchicine-resistant Familial Mediterranean Fever, Mevalonate Kinase Deficiency, and TRAPS treated with canakinumab.
Koné-Paut I; Piram M; Benseler S; Kuemmerle-Deschner JB; Jansson A; Rosner I; Tommasini A; Murias S; Karadag O; Levy J; McCreddin S; Migliaccio M; De Benedetti F
Joint Bone Spine; 2022 Nov; 89(6):105448. PubMed ID: 35944600
[TBL] [Abstract][Full Text] [Related]
3. Evidence-based provisional clinical classification criteria for autoinflammatory periodic fevers.
Federici S; Sormani MP; Ozen S; Lachmann HJ; Amaryan G; Woo P; Koné-Paut I; Dewarrat N; Cantarini L; Insalaco A; Uziel Y; Rigante D; Quartier P; Demirkaya E; Herlin T; Meini A; Fabio G; Kallinich T; Martino S; Butbul AY; Olivieri A; Kuemmerle-Deschner J; Neven B; Simon A; Ozdogan H; Touitou I; Frenkel J; Hofer M; Martini A; Ruperto N; Gattorno M;
Ann Rheum Dis; 2015 May; 74(5):799-805. PubMed ID: 25637003
[TBL] [Abstract][Full Text] [Related]
4. A preliminary score for the assessment of disease activity in hereditary recurrent fevers: results from the AIDAI (Auto-Inflammatory Diseases Activity Index) Consensus Conference.
Piram M; Frenkel J; Gattorno M; Ozen S; Lachmann HJ; Goldbach-Mansky R; Hentgen V; Neven B; Stojanovic KS; Simon A; Kuemmerle-Deschner J; Hoffman H; Stojanov S; Duquesne A; Pillet P; Martini A; Pouchot J; Koné-Paut I;
Ann Rheum Dis; 2011 Feb; 70(2):309-14. PubMed ID: 21081528
[TBL] [Abstract][Full Text] [Related]
5. The assessment of autoinflammatory disease classification criteria (Eurofever/PRINTO) in a real-life cohort.
Çağlayan Ş; Mardinoğlu G; Yarar MH; Ulu K; Coşkuner T; Yiğit RE; Baykal GÖ; Türkmen Ş; Çakan M; Demir F; Sözeri B
Clin Rheumatol; 2023 Jun; 42(6):1645-1653. PubMed ID: 36826737
[TBL] [Abstract][Full Text] [Related]
6. International Retrospective Chart Review of Treatment Patterns in Severe Familial Mediterranean Fever, Tumor Necrosis Factor Receptor-Associated Periodic Syndrome, and Mevalonate Kinase Deficiency/Hyperimmunoglobulinemia D Syndrome.
Ozen S; Kuemmerle-Deschner JB; Cimaz R; Livneh A; Quartier P; Kone-Paut I; Zeft A; Spalding S; Gul A; Hentgen V; Savic S; Foeldvari I; Frenkel J; Cantarini L; Patel D; Weiss J; Marinsek N; Degun R; Lomax KG; Lachmann HJ
Arthritis Care Res (Hoboken); 2017 Apr; 69(4):578-586. PubMed ID: 27723279
[TBL] [Abstract][Full Text] [Related]
7. Consensus protocols for the diagnosis and management of the hereditary autoinflammatory syndromes CAPS, TRAPS and MKD/HIDS: a German PRO-KIND initiative.
Hansmann S; Lainka E; Horneff G; Holzinger D; Rieber N; Jansson AF; Rösen-Wolff A; Erbis G; Prelog M; Brunner J; Benseler SM; Kuemmerle-Deschner JB
Pediatr Rheumatol Online J; 2020 Feb; 18(1):17. PubMed ID: 32066461
[TBL] [Abstract][Full Text] [Related]
8. Reasons for canakinumab initiation among patients with periodic fever syndromes: a retrospective medical chart review from the United States.
Hur P; Lomax KG; Ionescu-Ittu R; Manceur AM; Xie J; Cammarota J; Gautam R; Sanghera N; Kim N; Grom AA
Pediatr Rheumatol Online J; 2021 Sep; 19(1):143. PubMed ID: 34521444
[TBL] [Abstract][Full Text] [Related]
9. Monogenic Periodic Fever Syndromes: Treatment Options for the Pediatric Patient.
Ozen S; Demir S
Paediatr Drugs; 2017 Aug; 19(4):303-311. PubMed ID: 28497352
[TBL] [Abstract][Full Text] [Related]
10. Performance of Different Diagnostic Criteria for Familial Mediterranean Fever in Children with Periodic Fevers: Results from a Multicenter International Registry.
Demirkaya E; Saglam C; Turker T; Koné-Paut I; Woo P; Doglio M; Amaryan G; Frenkel J; Uziel Y; Insalaco A; Cantarini L; Hofer M; Boiu S; Duzova A; Modesto C; Bryant A; Rigante D; Papadopoulou-Alataki E; Guillaume-Czitrom S; Kuemmerle-Deschner J; Neven B; Lachmann H; Martini A; Ruperto N; Gattorno M; Ozen S; ;
J Rheumatol; 2016 Jan; 43(1):154-60. PubMed ID: 26568587
[TBL] [Abstract][Full Text] [Related]
11. In silico validation of the Autoinflammatory Disease Damage Index.
Ter Haar NM; van Delft ALJ; Annink KV; van Stel H; Al-Mayouf SM; Amaryan G; Anton J; Barron KS; Benseler S; Brogan PA; Cantarini L; Cattalini M; Cochino AV; de Benedetti F; Dedeoglu F; de Jesus AA; Demirkaya E; Dolezalova P; Durrant KL; Fabio G; Gallizzi R; Goldbach-Mansky R; Hachulla E; Hentgen V; Herlin T; Hofer M; Hoffman HM; Insalaco A; Jansson AF; Kallinich T; Kone-Paut I; Kozlova A; Kuemmerle-Deschner JB; Lachmann HJ; Laxer RM; Martini A; Nielsen S; Nikishina I; Ombrello AK; Özen S; Papadopoulou-Alataki E; Quartier P; Rigante D; Russo R; Simon A; Trachana M; Uziel Y; Ravelli A; Schulert G; Gattorno M; Frenkel J
Ann Rheum Dis; 2018 Nov; 77(11):1599-1605. PubMed ID: 30077992
[TBL] [Abstract][Full Text] [Related]
12. Classification criteria for autoinflammatory recurrent fevers.
Gattorno M; Hofer M; Federici S; Vanoni F; Bovis F; Aksentijevich I; Anton J; Arostegui JI; Barron K; Ben-Cherit E; Brogan PA; Cantarini L; Ceccherini I; De Benedetti F; Dedeoglu F; Demirkaya E; Frenkel J; Goldbach-Mansky R; Gul A; Hentgen V; Hoffman H; Kallinich T; Kone-Paut I; Kuemmerle-Deschner J; Lachmann HJ; Laxer RM; Livneh A; Obici L; Ozen S; Rowczenio D; Russo R; Shinar Y; Simon A; Toplak N; Touitou I; Uziel Y; van Gijn M; Foell D; Garassino C; Kastner D; Martini A; Sormani MP; Ruperto N;
Ann Rheum Dis; 2019 Aug; 78(8):1025-1032. PubMed ID: 31018962
[TBL] [Abstract][Full Text] [Related]
13. Validation of the new classification criteria for hereditary recurrent fever in an independent cohort: experience from the JIR Cohort Database.
Dingulu G; Georgin-Lavialle S; Koné-Paut I; Pillet P; Pagnier A; Merlin E; Kaiser D; Belot A; Hofer M; Hentgen V
Rheumatology (Oxford); 2020 Oct; 59(10):2947-2952. PubMed ID: 32125423
[TBL] [Abstract][Full Text] [Related]
14. Long-term safety and effectiveness of canakinumab in patients with monogenic autoinflammatory diseases: results from the interim analysis of the RELIANCE registry.
Kuemmerle-Deschner JB; Kallinich T; Henes J; Kortus-Götze B; Oommen PT; Rech J; Krickau T; Weller-Heinemann F; Horneff G; Janda A; Foeldvari I; Schuetz C; Dressler F; Borte M; Hufnagel M; Meier F; Fiene M; Andreica I; Weber-Arden J; Blank N
RMD Open; 2024 Feb; 10(1):. PubMed ID: 38360038
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the clinical diagnostic criteria and the results of the next-generation sequence gene panel in patients with monogenic systemic autoinflammatory diseases.
Sözeri B; Demir F; Sönmez HE; Karadağ ŞG; Demirkol YK; Doğan ÖA; Doğanay HL; Ayaz NA
Clin Rheumatol; 2021 Jun; 40(6):2327-2337. PubMed ID: 33165748
[TBL] [Abstract][Full Text] [Related]
16. Pattern and diagnostic evaluation of systemic autoinflammatory diseases other than familial Mediterranean fever among Arab children: a multicenter study from the Pediatric Rheumatology Arab Group (PRAG).
Al-Mayouf SM; Almutairi A; Albrawi S; Fathalla BM; Alzyoud R; AlEnazi A; Abu-Shukair M; Alwahadneh A; Alsonbul A; Zlenti M; Khawaja E; Abushhaiwia A; Khawaja K; AlMosawi Z; Madan W; Almuatiri M; Almuatiri N;
Rheumatol Int; 2020 Jan; 40(1):49-56. PubMed ID: 31741047
[TBL] [Abstract][Full Text] [Related]
17. Fast diagnostic test for familial Mediterranean fever based on a kinase inhibitor.
Magnotti F; Malsot T; Georgin-Lavialle S; Abbas F; Martin A; Belot A; Fauter M; Rabilloud M; Gerfaud-Valentin M; Sève P; Duquesne A; Hot A; Durupt S; Savey L; Giurgea I; Grateau G; Henry T; Jamilloux Y
Ann Rheum Dis; 2021 Jan; 80(1):128-132. PubMed ID: 33037005
[TBL] [Abstract][Full Text] [Related]
18. The 2021 EULAR/American College of Rheumatology Points to Consider for Diagnosis, Management and Monitoring of the Interleukin-1 Mediated Autoinflammatory Diseases: Cryopyrin-Associated Periodic Syndromes, Tumour Necrosis Factor Receptor-Associated Periodic Syndrome, Mevalonate Kinase Deficiency, and Deficiency of the Interleukin-1 Receptor Antagonist.
Romano M; Arici ZS; Piskin D; Alehashemi S; Aletaha D; Barron K; Benseler S; Berard RA; Broderick L; Dedeoglu F; Diebold M; Durrant K; Ferguson P; Foell D; Hausmann JS; Jones OY; Kastner D; Lachmann HJ; Laxer RM; Rivera D; Ruperto N; Simon A; Twilt M; Frenkel J; Hoffman HM; de Jesus AA; Kuemmerle-Deschner JB; Ozen S; Gattorno M; Goldbach-Mansky R; Demirkaya E
Arthritis Rheumatol; 2022 Jul; 74(7):1102-1121. PubMed ID: 35621220
[TBL] [Abstract][Full Text] [Related]
19. The 2021 EULAR/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated periodic syndrome, mevalonate kinase deficiency, and deficiency of the interleukin-1 receptor antagonist.
Romano M; Arici ZS; Piskin D; Alehashemi S; Aletaha D; Barron KS; Benseler S; Berard R; Broderick L; Dedeoglu F; Diebold M; Durrant KL; Ferguson P; Foell D; Hausmann J; Jones OY; Kastner DL; Lachmann HJ; Laxer RM; Rivera D; Ruperto N; Simon A; Twilt M; Frenkel J; Hoffman H; de Jesus AA; Kuemmerle-Deschner JB; Ozen S; Gattorno M; Goldbach-Mansky R; Demirkaya E
Ann Rheum Dis; 2022 Jul; 81(7):907-921. PubMed ID: 35623638
[TBL] [Abstract][Full Text] [Related]
20. Periodic fever syndromes.
Lachmann HJ
Best Pract Res Clin Rheumatol; 2017 Aug; 31(4):596-609. PubMed ID: 29773275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
